Recent Additions

Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:47 (1 month ago)
Date last modified: 2019/09/12 14:47 (1 month ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture + Novelty
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Plant
Production process: N/A
Source: N/A
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Bio-DEM™ by Lygos, Inc (Advanced Biofuels Process Demonstration Unit)
Biotech components: Enzyme + Gene Editing + Microbe + Plant
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:33 (1 month ago)
Date last modified: 2019/09/12 14:33 (1 month ago)
Known funding amount: N/A
Funding types: Shareholder Investment + Venture Capital
Industry: Industrial + Multipurpose
Market status: On the market
Organization type(s): Private Company
Product categories: Additive + Chemical
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:32 (1 month ago)
Date last modified: 2019/09/12 14:32 (1 month ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (1 month ago)
Date last modified: 2019/09/12 14:31 (1 month ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Non-browning avocado by Intrexon
Biotech components: Gene Editing
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (1 month ago)
Date last modified: 2019/09/12 14:31 (1 month ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Public Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product